NARSAD Congratulates Nobel Prize Winners of 2000

National Alliance for Research on Schizophrenia and Depression
Sunday, 1 October 2000

Great Neck, NY (October 2000). NARSAD congratulates the three outstanding researchers sharing this year's Nobel Prize in Medicine for their groundbreaking studies of the brain's billions of nerve cells and how they communicate with each other. All three scientists have been affiliated with NARSAD, either through a research grant or by receiving a NARSAD prize for their outstanding work. Two of the Nobel Prize winners currently serve on NARSAD's Scientific Council. NARSAD is proud to have recognized their efforts in the past, and we continue to salute their immeasurable contributions to the field of brain research.

Arvid Emil Carlsson, M.D., of Gothenburg University in Sweden, received NARSAD's Lieber Prize in 1994 for research which provided a key hypothesis for understanding schizophrenia, the first clinically active antidepressant, and the discovery of interactions providing new avenues for understanding brain malfunction and potential therapeutic strategies.

Paul Greengard, Ph.D., of Rockefeller University in New York City, is a member of NARSAD's Scientific Council. He was a Distinguished Investigator Grantee in 1992 and winner of NARSAD's Lieber Prize in 1996 for his leading role in elucidating the molecular mechanisms by which brain neurons communicate with each other.

Eric R. Kandel, M.D., of Columbia University in New York City, is a member of NARSAD's Scientific Council. He was a Distinguished Investigator Grantee in 1995 and 2000 for his research in a genetic approach to affective disorders and studies on the molecular mechanisms in the amygdala that govern the learned acquisition of anxiety, respectively.

For more information, or to contact National Alliance for Research on Schizophrenia and Depression, see their website at: www.narsad.org